This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Ferring B.v.. Active years: 2005-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2015
Title: Pierre J-m Riviere: Innovator in Medicinal Chemistry
Introduction
Pierre J-m Riviere is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicinal chemistry, holding a total of 3 patents. His work focuses on developing novel compounds for therapeutic applications, particularly in critical care.
Latest Patents
One of his latest patents is titled "Use of peptidic vasopression receptor agonists." This invention relates to the use of novel compounds for the manufacture of a medicament aimed at treating conditions associated with critical care. The compounds are administered according to a specific method defined in the patent. Another significant patent is "Serine protease genes related to DPPIV." This patent describes novel proteins or polypeptides that have significant sequence homology to DPPIV, along with nucleic acids coding for these proteins. It also includes modified cells that express these proteins, antibodies to these proteins, and methods for discovering new therapeutic agents.
Career Highlights
Pierre J-m Riviere is currently associated with Ferring B.V., a company known for its focus on innovative medicines. His work at Ferring B.V. has allowed him to explore and develop groundbreaking therapeutic solutions.
Collaborations
Some of his notable coworkers include Karen O Akinsanya and Jean-Louis Junien. Their collaborative efforts contribute to the advancement of research and development in the field of medicinal chemistry.
Conclusion
Pierre J-m Riviere's innovative work and patents reflect his commitment to improving healthcare through scientific advancements. His contributions continue to influence the field of medicinal chemistry significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
